Frontlight ResearchEarly access
TerminatedPhase 3
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Key facts
- Who runs it
- The University of Texas Medical Branch, Galveston
- Where
- Austin and Galveston, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- Phase
- Phase 3
- People taking part
- 453 people enrolled
- Started
- 21 Nov 2017
- Ended
- 22 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hydrochlorothiazide 50mg Tablet
- Placebo Tablet
- Record updated
- 14 July 2026
- Why it stopped
- Futility of the study
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Maternal age ≥ 18 years and <50 years
- Diagnosis of gestational hypertension* or preeclampsia\^ at any time during pregnancy, labor or postpartum; defined as isolated systolic BP of 140 mm Hg or greater, a diastolic BP of 90 mm Hg or greater, or both) or \^ defines as new-onset hypertension plus new-onset proteinuria, or in the absence of proteinuria, preeclampsia is diagnosed as hypertension in association with thrombocytopenia (platelet count less than 100,000/microliter), impaired liver function (elevated blood levels of liver transaminases to twice the normal concentration), the new development of renal insufficiency (elevated serum creatinine greater than 1.1 mg/dL or a doubling of serum creatinine in the absence of other renal disease), pulmonary edema, or new-onset cerebral or visual disturbances.)
Who cannot take part
- Subject requiring antihypertensive therapy at time of screening
- Planned discharge with oral anti-hypertensive medication
- Contraindication to hydrochlorothiazide (advanced renal failure or anuria, hypersensitivity to sulfonamides)
- Pre-gestational diabetes
- Subject not able to follow up postpartum
- Lactose intolerance
Where in United States
- St. David's North Austin Medical CenterAustin, United States
- University of Texas Medical BranchGalveston, United States
About the trial
What the trial wants to find out
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
The 2 groups in the trial
- Hydrochlorothiazide 50mg TabletExisting treatment, for comparison
Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.
- Placebo TabletPlacebo, for comparison
Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for fourteen days postpartum
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial
- Record updated
- 14 July 2026